For psychiatrist-led pathways, the design intent is to provide clinically relevant longitudinal summaries: symptom patterns, adherence reports, self-reported side effects, sleep and activity trends, and concise change notes that highlight meaningful shifts between visits. These summaries are meant to help psychiatrists prioritize diagnostic questions and medication-related decisions rather than substitute for them. Any medication choice, dose adjustment, laboratory investigation or hospitalization pathway remains explicitly under licensed professional control.
The envisioned system separates patient-reported items from device-derived or AI-synthesised inferences so that clinicians can weigh the evidence. Alerting logic can flag configured patterns for review—such as emergent insomnia with impaired functioning—while requiring human confirmation before any treatment change. Traceability, versioned summaries and clinician sign-off fields are part of the proposed psychiatry workflow to support safe, auditable medication management.
